(KMX) CarMax - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1431301027
Stock: Used Cars, Auto Financing, Protection Plans, Repair Services
Total Rating 32
Risk 80
Buy Signal -0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 41.3% |
| Relative Tail Risk | -12.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.98 |
| Alpha | -66.13 |
| Character TTM | |
|---|---|
| Beta | 0.899 |
| Beta Downside | 0.562 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.38% |
| CAGR/Max DD | -0.22 |
EPS (Earnings per Share)
Revenue
Description: KMX CarMax March 05, 2026
CarMax, Inc. (KMX) operates as a used vehicle retailer in the United States, with two primary segments: CarMax Sales Operations and CarMax Auto Finance.
The CarMax Sales Operations segment sells a variety of used vehicles and offers extended protection plans and vehicle repair services. This segment also conducts used vehicle auctions, a common practice in the automotive retail sector to manage inventory.
The CarMax Auto Finance segment provides financing options for retail customers. Offering in-house financing is a key component of many automotive retail business models, allowing companies to capture additional revenue and control the sales process.
For more detailed financial and operational data, ValueRay offers comprehensive analysis.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 457.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 6.39 > 1.0 |
| NWC/Revenue: 7.52% < 20% (prev 9.79%; Δ -2.27% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.48b > Net Income 457.8m |
| Net Debt (16.47b) to EBITDA (1.07b): 15.46 < 3 |
| Current Ratio: 1.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (149.4m) vs 12m ago -3.79% < -2% |
| Gross Margin: 11.31% > 18% (prev 0.11%; Δ 1120 % > 0.5%) |
| Asset Turnover: 105.3% > 50% (prev 101.8%; Δ 3.47% > 0%) |
| Interest Coverage Ratio: 6.79 > 6 (EBITDA TTM 1.07b / Interest Expense TTM 105.8m) |
Altman Z'' 1.48
| A: 0.08 (Total Current Assets 4.20b - Total Current Liabilities 2.11b) / Total Assets 25.56b |
| B: 0.16 (Retained Earnings 4.20b / Total Assets 25.56b) |
| C: 0.03 (EBIT TTM 718.3m / Avg Total Assets 26.43b) |
| D: 0.22 (Book Value of Equity 4.24b / Total Liabilities 19.50b) |
| Altman-Z'' Score: 1.48 = BB |
Beneish M -3.36
| DSRI: 0.71 (Receivables 151.1m/213.6m, Revenue 27.83b/27.80b) |
| GMI: 1.00 (GM 11.31% / 11.28%) |
| AQI: 0.99 (AQ_t 0.66 / AQ_t-1 0.67) |
| SGI: 1.00 (Revenue 27.83b / 27.80b) |
| TATA: -0.08 (NI 457.8m - CFO 2.48b) / TA 25.56b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of KMX shares?
As of March 06, 2026, the stock is trading at USD 42.05 with a total of 1,710,514 shares traded.
Over the past week, the price has changed by -1.89%, over one month by -7.52%, over three months by +8.32% and over the past year by -46.84%.
Over the past week, the price has changed by -1.89%, over one month by -7.52%, over three months by +8.32% and over the past year by -46.84%.
Is KMX a buy, sell or hold?
CarMax has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy KMX.
- StrongBuy: 8
- Buy: 4
- Hold: 4
- Sell: 3
- StrongSell: 0
What are the forecasts/targets for the KMX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.6 | -5.8% |
| Analysts Target Price | 39.6 | -5.8% |
KMX Fundamental Data Overview March 02, 2026
P/E Trailing = 14.1541
P/E Forward = 16.3132
P/S = 0.2278
P/B = 1.0094
P/EG = 0.6733
Revenue TTM = 27.83b USD
EBIT TTM = 718.3m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 16.59b USD (from longTermDebt, last quarter)
Short Term Debt = 796.6m USD (from shortTermDebt, last quarter)
Debt = 16.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.47b USD (from netDebt column, last quarter)
Enterprise Value = 22.81b USD (6.34b + Debt 16.68b - CCE 204.9m)
Interest Coverage Ratio = 6.79 (Ebit TTM 718.3m / Interest Expense TTM 105.8m)
EV/FCF = 11.70x (Enterprise Value 22.81b / FCF TTM 1.95b)
FCF Yield = 8.54% (FCF TTM 1.95b / Enterprise Value 22.81b)
FCF Margin = 7.00% (FCF TTM 1.95b / Revenue TTM 27.83b)
Net Margin = 1.65% (Net Income TTM 457.8m / Revenue TTM 27.83b)
Gross Margin = 11.31% ((Revenue TTM 27.83b - Cost of Revenue TTM 24.68b) / Revenue TTM)
Gross Margin QoQ = 10.64% (prev 10.63%)
Tobins Q-Ratio = 0.89 (Enterprise Value 22.81b / Total Assets 25.56b)
Interest Expense / Debt = 0.16% (Interest Expense 26.1m / Debt 16.68b)
Taxrate = 25.83% (21.7m / 83.9m)
NOPAT = 532.7m (EBIT 718.3m * (1 - 25.83%))
Current Ratio = 1.99 (Total Current Assets 4.20b / Total Current Liabilities 2.11b)
Debt / Equity = 2.75 (Debt 16.68b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = 15.46 (Net Debt 16.47b / EBITDA 1.07b)
Debt / FCF = 8.45 (Net Debt 16.47b / FCF TTM 1.95b)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.73% (Net Income 457.8m / Total Assets 25.56b)
RoE = 7.39% (Net Income TTM 457.8m / Total Stockholder Equity 6.20b)
RoCE = 3.15% (EBIT 718.3m / Capital Employed (Equity 6.20b + L.T.Debt 16.59b))
RoIC = 2.17% (NOPAT 532.7m / Invested Capital 24.54b)
WACC = 2.63% (E(6.34b)/V(23.02b) * Re(9.23%) + D(16.68b)/V(23.02b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 9.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.01%
[DCF] Terminal Value 80.82% ; FCFF base≈1.30b ; Y1≈856.2m ; Y5≈390.7m
[DCF] Fair Price = N/A (negative equity: EV 12.45b - Net Debt 16.47b = -4.02b; debt exceeds intrinsic value)
EPS Correlation: -29.17 | EPS CAGR: -56.88% | SUE: -0.89 | # QB: 0
Revenue Correlation: -46.19 | Revenue CAGR: -6.46% | SUE: 0.99 | # QB: 1
EPS next Quarter (2026-05-31): EPS=1.07 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+0 | Analysts=9
EPS next Year (2027-02-28): EPS=2.62 | Chg7d=+0.004 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=-2.9% | Growth Revenue=+0.5%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.2% (Discount Rate 9.2% - Earnings Yield 7.1%)
[Growth] Growth Spread = -5.9% (Analyst -3.7% - Implied 2.2%)
P/E Forward = 16.3132
P/S = 0.2278
P/B = 1.0094
P/EG = 0.6733
Revenue TTM = 27.83b USD
EBIT TTM = 718.3m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 16.59b USD (from longTermDebt, last quarter)
Short Term Debt = 796.6m USD (from shortTermDebt, last quarter)
Debt = 16.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.47b USD (from netDebt column, last quarter)
Enterprise Value = 22.81b USD (6.34b + Debt 16.68b - CCE 204.9m)
Interest Coverage Ratio = 6.79 (Ebit TTM 718.3m / Interest Expense TTM 105.8m)
EV/FCF = 11.70x (Enterprise Value 22.81b / FCF TTM 1.95b)
FCF Yield = 8.54% (FCF TTM 1.95b / Enterprise Value 22.81b)
FCF Margin = 7.00% (FCF TTM 1.95b / Revenue TTM 27.83b)
Net Margin = 1.65% (Net Income TTM 457.8m / Revenue TTM 27.83b)
Gross Margin = 11.31% ((Revenue TTM 27.83b - Cost of Revenue TTM 24.68b) / Revenue TTM)
Gross Margin QoQ = 10.64% (prev 10.63%)
Tobins Q-Ratio = 0.89 (Enterprise Value 22.81b / Total Assets 25.56b)
Interest Expense / Debt = 0.16% (Interest Expense 26.1m / Debt 16.68b)
Taxrate = 25.83% (21.7m / 83.9m)
NOPAT = 532.7m (EBIT 718.3m * (1 - 25.83%))
Current Ratio = 1.99 (Total Current Assets 4.20b / Total Current Liabilities 2.11b)
Debt / Equity = 2.75 (Debt 16.68b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = 15.46 (Net Debt 16.47b / EBITDA 1.07b)
Debt / FCF = 8.45 (Net Debt 16.47b / FCF TTM 1.95b)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.73% (Net Income 457.8m / Total Assets 25.56b)
RoE = 7.39% (Net Income TTM 457.8m / Total Stockholder Equity 6.20b)
RoCE = 3.15% (EBIT 718.3m / Capital Employed (Equity 6.20b + L.T.Debt 16.59b))
RoIC = 2.17% (NOPAT 532.7m / Invested Capital 24.54b)
WACC = 2.63% (E(6.34b)/V(23.02b) * Re(9.23%) + D(16.68b)/V(23.02b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 9.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.01%
[DCF] Terminal Value 80.82% ; FCFF base≈1.30b ; Y1≈856.2m ; Y5≈390.7m
[DCF] Fair Price = N/A (negative equity: EV 12.45b - Net Debt 16.47b = -4.02b; debt exceeds intrinsic value)
EPS Correlation: -29.17 | EPS CAGR: -56.88% | SUE: -0.89 | # QB: 0
Revenue Correlation: -46.19 | Revenue CAGR: -6.46% | SUE: 0.99 | # QB: 1
EPS next Quarter (2026-05-31): EPS=1.07 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+0 | Analysts=9
EPS next Year (2027-02-28): EPS=2.62 | Chg7d=+0.004 | Chg30d=+0.014 | Revisions Net=+1 | Growth EPS=-2.9% | Growth Revenue=+0.5%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.2% (Discount Rate 9.2% - Earnings Yield 7.1%)
[Growth] Growth Spread = -5.9% (Analyst -3.7% - Implied 2.2%)